Gainers
- SAB Biotherapeutics (NASDAQ:SABS) stock increased by 97.3% to $0.75 during Thursday’s pre-market session. The company’s market cap stands at $37.7 million.
- Predictive Oncology (NASDAQ:POAI) shares rose 28.82% to $0.35. The company’s market cap stands at $28.1 million.
- Regulus Therapeutics (NASDAQ:RGLS) shares moved upwards by 24.43% to $1.12. The company’s market cap stands at $18.8 million.
- Medigus (NASDAQ:MDGS) stock increased by 19.36% to $5.24. The market value of their outstanding shares is at $8.5 million.
- Benitec Biopharma (NASDAQ:BNTC) shares moved upwards by 18.3% to $0.25. The market value of their outstanding shares is at $6.9 million.
- Vincerx Pharma (NASDAQ:VINC) stock rose 17.7% to $1.13. The company’s market cap stands at $24.0 million.
Losers
- GlucoTrack (NASDAQ:GCTK) stock declined by 37.4% to $1.69 during Thursday’s pre-market session. The market value of their outstanding shares is at $26.2 million.
- ViewRay (NASDAQ:VRAY) stock declined by 25.92% to $2.23. The company’s market cap stands at $405.4 million.
- Sarepta Therapeutics (NASDAQ:SRPT) shares fell 17.93% to $113.0. The market value of their outstanding shares is at $9.9 billion.
- Creative Medical Tech (NASDAQ:CELZ) stock fell 12.58% to $0.77. The company’s market cap stands at $10.7 million.
- Trxade Health (NASDAQ:MEDS) stock fell 8.6% to $0.28. The market value of their outstanding shares is at $2.7 million.
- Lucy Scientific Discovery (NASDAQ:LSDI) stock decreased by 8.0% to $0.92. The market value of their outstanding shares is at $15.0 million.
See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
